Drug Approval | June 19, 2023
Lupin launches Thiamine Hydrochloride Injection USP in the US
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the U.S.
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Rocuronium Bromide Injection is a neuromuscular blocking agent
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The approval allows it to market its products in the country
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Subscribe To Our Newsletter & Stay Updated
